Researchers show for the first time that human immune cells contain particles that have neurotransmitters including dopamine, which plays a crucial role in immune responses.
"These particles were previously thought to only exist in neurons in the brain and we think they are, potentially, an excellent target for therapies to speed up or dampen the body's immune response, depending on the disease you're dealing with," said the author.
Neurons rely on synaptic interactions and neurotransmitters such as dopamine, which are small molecules transmitted across synapses to deliver signals from one cell to another that play a major role in reward-motivated behavior.
Authors show that a proportion of human TFH cells contain dense-core granules marked by chromogranin B, which are normally found in neuronal presynaptic terminals storing catecholamines such as dopamine. TFH cells produce high amounts of dopamine and release it upon cognate interaction with B cells.
"Like neurons, specialised T cells transfer dopamine to B cells that provides additional 'motivation' for B cells to produce the best antibodies they can to help to clear up an infection," author said.
"The human body has developed an advanced form of protection against bacteria, viruses and other foreign bodies that relies on the immune system.
"Immune responses are essential for recognizing and defending humans against substances that appear foreign and harmful to the individual."
Dopamine causes rapid translocation of intracellular ICOSL (inducible T-cell co-stimulator ligand, also known as ICOSLG) to the B-cell surface, which enhances accumulation of CD40L and chromogranin B granules at the human TFHcell synapse and increases the synapse area.
The researchers analyzed around 200 tissue samples from children who had their tonsils removed, observing the transfer of dopamine from specialized T cells to B cells through a synaptic interaction.
They also worked with a mathematician to model the immune system's brain-like activity in a human in response to vaccines.
https://www.nature.com/nature/journal/vaop/ncurrent/full/nature23013.html
Latest News
Abusive drugs hijack natura…
By newseditor
Posted 23 Apr
Mechanism of action of the…
By newseditor
Posted 23 Apr
Role of fat in rare neurolo…
By newseditor
Posted 23 Apr
How protein synthesis in de…
By newseditor
Posted 22 Apr
Atlas of mRNA variants in d…
By newseditor
Posted 22 Apr
Other Top Stories
Epigenetic mechanisms control HIV susceptibility
Read more
Inflammation and microRNA connection to muscular dystrophy
Read more
A distinct function of regulatory T cells in tissue protection
Read more
Novel role of mitochondria in immune function
Read more
Sugar governs how antibodies work in the immune system
Read more
Protocols
A programmable targeted pro…
By newseditor
Posted 23 Apr
MemPrep, a new technology f…
By newseditor
Posted 08 Apr
A tangible method to assess…
By newseditor
Posted 08 Apr
Stem cell-derived vessels-o…
By newseditor
Posted 06 Apr
Single-cell biclustering fo…
By newseditor
Posted 01 Apr
Publications
Exploiting pancreatic cance…
By newseditor
Posted 23 Apr
Structure of antiviral drug…
By newseditor
Posted 23 Apr
Type-I-interferon-responsiv…
By newseditor
Posted 23 Apr
Selenium, diabetes, and the…
By newseditor
Posted 23 Apr
Long-term neuropsychologica…
By newseditor
Posted 23 Apr
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar